Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism GABRA5 modulators(Gamma-aminobutyric acid A receptor alpha-5 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autism Spectrum Disorder | Preclinical | US | 01 Feb 2024 | |
Mild cognitive disorder | Preclinical | US | 01 Feb 2024 | |
Schizophrenia | Preclinical | US | 01 Feb 2024 |